Ligand validation:6JLO

PHO: PHEOPHYTIN A

PHO is a Ligand Of Interest in 6JLO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JLO_PHO_A_407	62%	15%	0.158	0.952	1.88	1.88	8	11	0	0	100%	1
6JLO_PHO_D_402	58%	16%	0.172	0.953	1.89	1.82	8	9	0	0	100%	0.49
6JLO_PHO_d_402	57%	15%	0.176	0.952	1.85	1.95	8	10	0	0	100%	0.49
6JLO_PHO_a_410	56%	18%	0.189	0.963	1.86	1.67	8	9	0	0	100%	1
5GTI_PHO_a_407	100%	15%	0.036	0.978	1.85	1.92	7	12	0	0	100%	1
5WS6_PHO_A_407	99%	17%	0.047	0.977	1.82	1.82	7	10	0	0	100%	1
5V2C_PHO_A_608	98%	28%	0.059	0.979	1.52	1.37	8	7	0	0	100%	1
5B66_PHO_A_403	96%	27%	0.068	0.978	1.34	1.59	6	8	0	0	100%	1
8IRF_PHO_a_407	95%	16%	0.075	0.98	1.83	1.87	8	9	0	0	100%	0.49
7YQ7_PHO_A_407	96%	20%	0.069	0.979	1.7	1.65	7	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.